SEARCH

SEARCH BY CITATION

References

  • 1
    Vogelstein B, Kinzler K. The Genetic Basis of Human Cancer, 2nd ed. New York: McGraw-Hill, 2002.
  • 2
    Hemminki K, Eng C. Clinical genetic counselling for familial cancers requires reliable data on familial cancer risks and general action plans. J Med Genet 2004; 41: 8017.
  • 3
    Smith RA, Cokkinides V, Eyre HJ. American Cancer Society guidelines for the early detection of cancer, 2006. CA Cancer J Clin 2006; 56: 1125; quiz 49–50.
  • 4
    Futreal PA, Coin L, Marshall M, Down T, Hubbard T, Wooster R, Rahman N, Stratton MR. A census of human cancer genes. Nat Rev Cancer 2004; 4: 17783.
  • 5
    Mulvihill J, Davis S, Fromkin K. The catalog of human genes predisposing to neoplasia. In: WeberW, NaridS, MulvihillJ, eds. Familial cancer management. Boca Raton: CRC Press, 1996. 20337.
  • 6
    Vogelstein B, Kinzler KW. Cancer genes and the pathways they control. Nat Med 2004; 10: 78999.
  • 7
    Leu M, Czene K, Reilly M. The impact of truncation and missing family links in population-based registers on familial risk estimates. Am J Epidemiol 2007; 166: 14617.
  • 8
    Leu M, Reilly M, Czene K. Evaluation of bias in familial risk estimates: a study of common cancers using Swedish population-based registers. J Natl Cancer Inst 2008; 100: 131825.
  • 9
    Goldgar DE, Easton DF, Cannon-Albright LA, Skolnick MH. Systematic population-based assessment of cancer risk in first-degree relatives of cancer probands. J Natl Cancer Inst 1994; 86: 16007.
  • 10
    Amundadottir LT, Thorvaldsson S, Gudbjartsson DF, Sulem P, Kristjansson K, Arnason S, Gulcher JR, Bjornsson J, Kong A, Thorsteinsdottir U, Stefansson K. Cancer as a complex phenotype: pattern of cancer distribution within and beyond the nuclear family. PLoS Med 2004; 1: e65.
  • 11
    Tryggvadottir L, Sigvaldason H, Olafsdottir GH, Jonasson JG, Jonsson T, Tulinius H, Eyfjord JE. Population-based study of changing breast cancer risk in Icelandic BRCA2 mutation carriers, 1920–2000. J Natl Cancer Inst 2006; 98: 11622.
  • 12
    Olsen J, Hahnemann J, Börresen-Dale A-L, Bröndum-Nielsen K, Hammarström L, Kleinerman R, Kääriäinen H, Lönnqvist T, Sankila R, Seesholm N, Tretli S, Yuen J, et al. Cancer in patients with ataxia-telangiectasia and in their relatives in the Nordic countries. J Natl Cancer Inst 2001; 93: 1217.
  • 13
    Sankila R, Olsen JH, Anderson H. Risk of cancer among offspring of childhood-cancer survivors. N Engl J Med 1998; 338: 133944.
  • 14
    Winther JF, Sankila R, Boice JD, Tulinius H, Bautz A, Barlow L, Glattre E, Langmark F, Moller TR, Mulvihill JJ, Olafsdottir GH, Ritvanen A, et al. Cancer in siblings of children with cancer in the Nordic countries: a population-based cohort study. Lancet 2001; 358: 7117.
  • 15
    Hemminki K, Tretli S, Sundquist J, Johannesen TB, Granstrom C. Familial risks in nervous-system tumours: a histology-specific analysis from Sweden and Norway. Lancet Oncol 2009; 10: 4818.
  • 16
    Hemminki K, Vaittinen P. National database of familial cancer in Sweden. Genet Epidemiol 1998; 15: 22536.
  • 17
    Hemminki K, Li X, Plna K, Granström C, Vaittinen P. The nation-wide Swedish family-cancer database: updated structure and familial rates. Acta Oncol 2001; 40: 7727.
  • 18
    Hemminki K, Granström C, Chen B. The Swedish family-cancer database? Update, application to colorectal cancer and clinical relevance. Heredit Cancer Clin Pract 2005; 3: 718.
  • 19
    Hemminki K, Granström C, Sundquist J, Lorenzo Bermejo J. The updated Swedish family-cancer database used to assess familial risks of prostate cancer during rapidly increasing incidence. Heredit Cancer in Clin Pract 2006; 4: 18692.
  • 20
    Kerber RA, O'Brien E. A cohort study of cancer risk in relation to family histories of cancer in the Utah population database. Cancer 2005; 103: 190615.
  • 21
    Hampel H, Stephens JA, Pukkala E, Sankila R, Aaltonen LA, Mecklin JP, de la Chapelle A. Cancer risk in hereditary nonpolyposis colorectal cancer syndrome: later age of onset. Gastroenterology 2005; 129: 41521.
  • 22
    Centre for Epidemiology. Cancer incidence in Sweden 2005 ed. Stockholm: The National Board of Health and Welfare, 2007.
  • 23
    Hemminki K, Li X. Familial risk of cancer by site and histopathology. Int J Cancer 2003; 103: 1059.
  • 24
    Hemminki K, Li X. Familial risk in testicular cancer as a clue to a heritable and environmental aetiology. Br J Cancer 2004; 90: 176570.
  • 25
    Hemminki K, Chen B. Familial risks for eye melanoma and retinoblastoma: results from the Swedish family-cancer database. Melanoma Res 2006; 16: 1915.
  • 26
    Lakhani SR, Gusterson BA, Jacquemier J, Sloane JP, Anderson TJ, van de Vijver MJ, Venter D, Freeman A, Antoniou A, McGuffog L, Smyth E, Steel CM, et al. The pathology of familial breast cancer: histological features of cancers in families not attributable to mutations in BRCA1 or BRCA2. Clin Cancer Res 2000; 6: 7829.
  • 27
    Lakhani SR, O'Hare MJ, Ashworth A. Profiling familial breast cancer. Nat Med 2001; 7: 40810.
  • 28
    Hamilton S, Aaltonen L. Tumours of the digestive system World Health Organization classification of tumours. Lyon: IARC, 2000. 314p.
  • 29
    Eble J, Sauter G, Epstein J, Sesterhenn I. Tumors of the urinary system and male genital organs WHO Classification of Tumors, Pathology and Genetics. Lyon: IARC Press, 2003. 359p.
  • 30
    Li X, Hemminki K. Inherited predisposition to early onset lung cancer according to histological type. Int J Cancer 2004; 112: 4517.
  • 31
    Parkin DM, Khlat M. Studies of cancer in migrants: rationale and methodology. Eur J Cancer 1996; 32A: 76171.
  • 32
    Hemminki K, Lorenzo Bermejo J, Försti A. The balance between heritable and environmental aetiology of human disease. Nat Rev Genet 2006; 7: 95865.
  • 33
    Hemminki K, Li X. Cancer risks in second-generation immigrants to Sweden. Int J Cancer 2002; 99: 22937.
  • 34
    Hemminki K, Li X, Czene K. Cancer risks in first generation immigrants to Sweden. Int J Cancer 2002; 99: 21828.
  • 35
    Hemminki K, Li X. Finnish and Swedish genotypes and risk of cancer in Sweden. Eur J Hum Genet 2003; 11: 2079.
  • 36
    Hartman M, Lindstrom L, Dickman PW, Adami HO, Hall P, Czene K. Is breast cancer prognosis inherited? Breast Cancer Res 2007; 9: R39.
  • 37
    Hemminki K, Ji J, Forsti A, Sundquist J, Lenner P. Survival in breast cancer is familial. Breast Cancer Res Treat 2008; 110: 17782.
  • 38
    Hemminki K, Ji J, Försti A, Sundquist J, Lenner P. Concordance of survival in family members with prostate cancer. J Clin Oncol 2008; 26: 17059.
  • 39
    Lindstrom LS, Hall P, Hartman M, Wiklund F, Gronberg H, Czene K. Familial concordance in cancer survival: a Swedish population-based study. Lancet Oncol 2007; 8: 10016.
  • 40
    Hemminki K, Sundquist J, Lorenzo Bermejo J. Familial risks for cancer as the basis for evidence-based clinical referral and counseling. The Oncologist 2008; 13: 23947.
  • 41
    Murff HJ, Spigel DR, Syngal S. Does this patient have a family history of cancer? An evidence-based analysis of the accuracy of family cancer history. JAMA 2004; 292: 14809.
  • 42
    IARC. Cancer Incidence in Five Continents. In: ParkinD, WhelanS, FerlayJ, TeppoL, ThomasD, eds. vol. VIII. Lyon: IARC, 2002. 781 p.
  • 43
    Peto J. Cancer epidemiology in the last century and the next decade. Nature 2001; 411: 3905.
  • 44
    Stewart B, Kleihues P. World cancer report. Lyon: IARC Press, 2003. 351p.
  • 45
    Polednak A. Trends in cancer incidence in Connecticut, 1935–1991. Cancer 1994; 74: 286372.
  • 46
    Hemminki K, Jiang Y. Cancer risks among long-standing spouses. Br J Cancer 2002; 86: 173740.